Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1833-1839

  Tanner, Minna M ^a,b   Grenman, Seija ^c   Koul, Anjila ^b   Johannsson, Oskar ^b   Meltzer, Paul ^d   Pejovic, Tanja ^e   Borg, Åke ^b   Isola, Jorma J ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b LUND UNIVERSITY   (Sweden)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME 20Q; FEMALE; GENE AMPLIFICATION; GENE CONTROL; GENE FREQUENCY; HUMAN; HUMAN CELL; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 20; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0034025874     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Courjal, F., Cuny, M., Rodriguez, C., Louason, G., Speiser, P., Katsaros, D., Tanner, M. M., Zeillinger, R., and Theillet, C. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br. J. Cancer, 74: 1984-1999, 1996.
2. Pejovic, T. Genetic changes in ovarian cancer. Ann. Med., 27: 73-78, 1995.
3. Tirkkonen, M., Tanner, M., Karhu, R., Kallioniemi, A., Isola, J., and Kallioniemi, O. P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer, 21: 177-184, 1998.
4. Tirkkonen, M., Johannsson, O., Agnarsson, B. A., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R. B., Borg, A., and Kallioniemi, O. P. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
5. Sonoda, G., Palazzo, J., du Manoir, S., Godwin, A. K., Feder, M., Yakushiji, M., and Testa, J. R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer, 20: 320-328, 1997.
6. Arnold, N., Hagele, L., Walz, L., Schempp, W., Pfisterer, J., Bauknecht, T., and Kiechle, M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer, 16: 46-54, 1996.
7. Iwabuchi, H., Sakamoto, M., Sakunaga, H., Ma, Y. Y., Carcangiu, M. L., Pinkel, D., Yang-Feng, T. L., and Gray, J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res., 55: 6172-6180, 1995.
8. Tapper, J., Sarantaus, L., Vahteristo, P., Nevanlinna, H., Hemmer, S., Seppala, M., Knuutila, S., and Butzow, R. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32. Cancer Res., 58: 2715-2719, 1998.
9. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Isola, J., Kuukasjarvi, T., Collins, C., Kowbel, D., Guan, X. Y., Trent, J., Gray, J. W., Meltzer, P., and Kallioniemi, O. P. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res., 56: 3441-3445, 1996.
10. Guan, X.-Y., Xu, J., Anzick, S. L., Zhang, H., Trent, J. M., and Meltzer, P. S. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res., 56: 3446-3450, 1996.
11. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X. Y., Sauter, G., Kallioniemi, O. P., Trent, J. M., and Meltzer, P. S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (Washington DC), 277: 965-968, 1997.
12. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O.-P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
13. Collins, C., Rommens, J. M., Kowbel, D., Godfrey, T., Tanner, M., Hwang, S. I., Polikoff, D., Nonet, G., Cochran, J., Myambo, K., Jay, K. E., Froula, J., Cloutier, T., Kuo, W. L., Yaswen, P., Dairkee, S., Giovanola, J., Hutchinson, G. B., Isola, J., Kallioniemi, O. P., Palazzolo, M., Martin, C., Ericsson, C., Pinkel, D., Albertson, D., Li, W. B., and Gray, J. W. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc. Natl. Acad. Sci. USA, 95: 8703-8708, 1998.
14. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R., and Sen, S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet., 20: 189-193, 1998.
15. Helin, H., Kallioniemi, O. P., and Isola, J. J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Cancer (Phila.), 63: 1761-1767, 1989.
16. Fernö, M., Borg, A., Johansson, U., Norgren, A., Olsson, H., Ryden, S., and Sellberg, G. Estrogen and progesterone receptor analyses in more than 4000 human breast cancer samples. Acta Oncol., 29: 129-135, 1990.
17. Kallioniemi, O. P., Kallioniemi, A., Piper, J., Isola, J., Waldman, F. M., Gray, J. W., and Pinkel, D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer, 3: 5929-5933, 1993.
18. Stokke, T., Collins, C., Kuo, W. L., Kowbel, D., Shadravan, F., Tanner, M., Kallioniemi, A., Kallioniemi, O. P., Pinkel, D., Deaven, L., and Gray, J. W. A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics, 26: 134-137, 1995.
19. Johannsson, O. T., Idvall, I., Anderson, C., Borg, A., Barkardottir, R. B., Egilsson, V., Olsson, H. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
20. Rhei, E., Bogomolniy, F., Federici, M. G., Maresco, D. L., Offit, K., Robson, M. E., Saigo, P. E., and Boyd, J. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer Res., 58: 3193-3196, 1998.
21. Bautista, S., Valles, H., Walker, R. L., Anzick, S., Zeillinger, R., Meltzer, P., and Theillet, C. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res., 4: 2925-2929, 1998.
22. Isola, J., Kallioniemi, O. P., Korte, J. M., Wahlstrom, T., Aine, R., Helle, M., and Helin, H. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J. Pathol., 162: 295-301, 1990.
23. Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst., 90: 1774-1786, 1998.
24. Wiener, J. R., Kerns, B. J., Harvey, E. L., Conaway, M. R., Iglehart, J. D., Berchuck, A., and Bast, R. C. Jr. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J. Natl. Cancer Inst., 86: 372-378, 1994.
25. Wiener, J. R., Hurteau, J. A., Kerns, B. J., Whitaker, R. S., Conaway, M. R., Berchuck, A., and Bast, R. C. Jr. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am. J. Obstet. Gynecol., 170: 1177-1783, 1994.
26. Barlund, M, Tirkkonen, M., Forozan, F., Tanner, M. M., Kallioniemi, O., and Kallioniemi, A. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer, 20: 372-376, 1997.
27. Guan, X. Y., Meltzer, P. S., Dalton, W. S., and Trent, J. M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat. Genet., 8: 155-161, 1994.